首页> 外文期刊>BMC Cancer >Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer
【24h】

Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer

机译:基于同质和异质相关因素的线型图预测不同组织学类型肺癌患者的骨转移

获取原文
           

摘要

The purpose of the present study was to characterize the prevalence, associated factors, and to construct a nomogram for predicting bone metastasis (BM) with different histological types of lung cancer. This study was a descriptive study that basing on the invasive lung cancer patients diagnosed between 2010 and 2014 in Surveillance, Epidemiology, and End Results program. A total of 125,652 adult patients were retrieved. Logistic regression analysis was conducted to investigate homogeneous and heterogeneous factors for BM occurrence. Nomogram was constructed to predict the risk for developing BM and the performance was evaluated by the receiver operating characteristics curve (ROC) and the calibration curve. The overall survival of the patients with BM was analyzed using the Kaplan–Meier method and the survival differences were tested by the log-rank test. A total of 25,645 (20.9%) were reported to have BM, and the prevalence in adenocarcinoma, squamous cell carcinoma, small cell lung cancer (SCLC), large cell lung cancer (LCLC), and non-small cell lung cancerot otherwise specified lung cancer (NSCLC/NOS) were 24.4, 12.5, 24.7, 19.5 and 19.4%, respectively, with significant difference (P??0.001). Male gender, more metastatic sites and lymphatic metastasis were positively associated with BM in all lung cancer subtypes. Larger tumor size was positively associated with BM in all the lung cancer subtypes except for NSCLC/NOS. Poorly differentiated histology was positively associated with adenocarcinoma, squamous cell carcinoma and NSCLC/NOS. The calibration curve and ROC curve exhibited good performance for predicting BM. The median survival of the bone metastatic lung cancer patients was 4.00 (95%CI: 3.89–4.11) months. With the increased number of the other metastatic sites (brain, lung and liver metastasis), the survival significantly decreased (p??0.001). Different lung cancer histological subtypes exhibited distinct prevalence and homogeneity and heterogeneity associated factors for BM. The nomogram has good calibration and discrimination for predicting BM of lung cancer.
机译:本研究的目的是表征患病率,相关因素,并构建诺模图以预测具有不同组织学类型肺癌的骨转移(BM)。这项研究是一项描述性研究,依据的是在2010年至2014年之间通过监测,流行病学和最终结果计划诊断出的浸润性肺癌患者。共检索到125652名成年患者。进行Logistic回归分析以调查BM发生的同质和异质因素。构造了诺法图以预测发生BM的风险,并通过接收器工作特性曲线(ROC)和校准曲线评估了性能。使用Kaplan–Meier方法分析了BM患者的整体生存率,并通过对数秩检验检验了生存差异。据报道总共有25,645名(20.9%)患有BM,其患病率在腺癌,鳞状细胞癌,小细胞肺癌(SCLC),大细胞肺癌(LCLC)和非小细胞肺癌中特定肺癌(NSCLC / NOS)分别为24.4%,12.5、24.7、19.5和19.4%,差异有统计学意义(P <0.001)。在所有肺癌亚型中,男性,更多的转移部位和淋巴转移与BM呈正相关。除NSCLC / NOS外,所有肺癌亚型中较大的肿瘤大小均与BM呈正相关。组织学差分化与腺癌,鳞状细胞癌和NSCLC / NOS呈正相关。校准曲线和ROC曲线表现出良好的预测BM的性能。骨转移性肺癌患者的中位生存期为4.00(95%CI:3.89–4.11)个月。随着其他转移部位(脑,肺和肝转移)的增加,存活率显着下降(p <0.001)。不同的肺癌组织学亚型表现出与BM不同的患病率,同质性和异质性相关因素。诺模图具有良好的校准和判别能力,可预测肺癌的BM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号